The palliative performance scale applied in high-care residential hospice: a retrospective study.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 25122510.
- Also identified by DOI 10.1089/jpm.2013.0645.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The Palliative Performance Scale (PPS) is a tool that is widely used to predict end of life. In Ontario, Canada, the PPS is used to mark the terminal phase of life and eligibility for terminal care. The aim of this retrospective study was to confirm that a PPS level of 40% can be used as a marker for the terminal phase of life. PPS levels from 78 patients were calculated based on the intake reports made at admission to an inpatient hospice. Although 77 patients passed away within a period of 3 months, PPS levels at admission varied from 10% to 70%. Fifty-six percent of all patients had a PPS level of 40% or less. Regarding survival, three significant PPS profiles, consisting of two or more PPS levels could be distinguished.
Medical subject headings
- Eligibility Determination
- Hospice Care
- Karnofsky Performance Status
- Palliative Care
- Terminal Care